Cargando…

Association between ICS use and risk of hyperglycemia in COPD patients: systematic review and meta-analysis

BACKGROUND: The effect of inhaled corticosteroids (ICS) on risk of hyperglycemia in patients with chronic obstructive pulmonary disease (COPD) remains ambiguous. The aim of this study is to evaluate the association between ICS use and the incidence of hyperglycemia related adverse effects in COPD pa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pu, Xiaofeng, Liu, Liang, Feng, Bimin, Zhang, Zhengji, Wang, Guojun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8265114/ https://www.ncbi.nlm.nih.gov/pubmed/34238280 http://dx.doi.org/10.1186/s12931-021-01789-7

Ejemplares similares

Low-dose theophylline in addition to ICS therapy in COPD patients: A systematic review and meta-analysis
por: Shuai, Tiankui, et al.
Publicado: (2021)

Comparison of Characteristics Between ICS-Treated COPD Patients and ICS-Treated COPD Patients with Concomitant Asthma: A Study in Primary Care
por: Savran, Osman, et al.
Publicado: (2020)

LABA/LAMA combinations versus LAMA monotherapy or LABA/ICS in COPD: a systematic review and meta-analysis
por: Rodrigo, Gustavo J, et al.
Publicado: (2017)

Efficacy of ICS versus Non-ICS Combination Therapy in COPD: A Meta-Analysis of Randomised Controlled Trials
por: Ding, Yanling, et al.
Publicado: (2022)

ICS and COPD: Time to clear the air
por: Ford, Paul A, et al.
Publicado: (2009)

Comparative efficacy of inhaled medications (ICS/LABA, LAMA, LAMA/LABA and SAMA) for COPD: a systematic review and network meta-analysis
por: Aziz, Mohamed Ismail Abdul, et al.
Publicado: (2018)

Association Between Serum Cystatin C and Thyroid Diseases: A Systematic Review and Meta-Analysis
por: Xin, Caihong, et al.
Publicado: (2021)

The association between cystatin C and COPD: a meta-analysis and systematic review
por: Chai, Limin, et al.
Publicado: (2020)

Abdominal Obesity and Lung Cancer Risk: Systematic Review and Meta-Analysis of Prospective Studies
por: Hidayat, Khemayanto, et al.
Publicado: (2016)

ICS-formoterol reliever versus ICS and short-acting β(2)-agonist reliever in asthma: a systematic review and meta-analysis
por: Hatter, Lee, et al.
Publicado: (2021)

The association between vitamin D and COPD risk, severity, and exacerbation: an updated systematic review and meta-analysis
por: Zhu, Min, et al.
Publicado: (2016)

Efficacy and Safety of Non-Steroidal Mineralocorticoid Receptor Antagonists in Patients With Chronic Kidney Disease and Type 2 Diabetes: A Systematic Review Incorporating an Indirect Comparisons Meta-Analysis
por: Jiang, Xinrui, et al.
Publicado: (2022)

The association between diabetes/hyperglycemia and the prognosis of cervical cancer patients: A systematic review and meta-analysis
por: Chen, Shu, et al.
Publicado: (2017)

Is the Combination of ICS and LABA, a Therapeutic Option for COPD, Fading Away?
por: Oh, Yeon-Mok
Publicado: (2017)

Triple therapy (ICS/LABA/LAMA) in COPD: time for a reappraisal
por: Vanfleteren, Lowie, et al.
Publicado: (2018)

Triple therapy (ICS/LABA/LAMA) in COPD: thinking out of the box
por: Vanfleteren, Lowie E.G.W., et al.
Publicado: (2019)

The Association between Use of ICS and Psychiatric Symptoms in Patients with COPD—A Nationwide Cohort Study of 49,500 Patients
por: Jordan, Alexander, et al.
Publicado: (2021)

Association between inhaled corticosteroid use and risk of hyperglycemia in patients with chronic obstructive pulmonary disease: A systematic review and meta-analysis
por: Kholis, Fathur Nur, et al.
Publicado: (2023)

Effect of Fenugreek on Hyperglycemia: A Systematic Review and Meta-Analysis
por: Shabil, Muhammed, et al.
Publicado: (2023)

Association between hyperglycemia and retinopathy of prematurity: a systemic review and meta-analysis
por: Au, Sunny C. L., et al.
Publicado: (2015)

Admission hyperglycemia in acute myocardial infarction is associated with an increased risk of arrhythmias: A systematic review and meta‐analysis
por: Trongtorsak, Angkawipa, et al.
Publicado: (2022)

Reduced risk of clinically important deteriorations by ICS in COPD is eosinophil dependent: a pooled post-hoc analysis
por: Bafadhel, Mona, et al.
Publicado: (2020)

Associations between statins and COPD: a systematic review
por: Dobler, Claudia C, et al.
Publicado: (2009)

Association between varying cut-points of intermediate hyperglycemia and risk of mortality, cardiovascular events and chronic kidney disease: a systematic review and meta-analysis
por: Gujral, Unjali P, et al.
Publicado: (2021)

Predictors of ICS/LABA prescribing in COPD patients: a study from general practice
por: Drivenes, Elin, et al.
Publicado: (2014)

LAMA/LABA vs ICS/LABA in the treatment of COPD in Japan based on the disease phenotypes
por: Hizawa, Nobuyuki
Publicado: (2015)

Glucocorticoid-Induced Hyperglycemia Including Dexamethasone-Associated Hyperglycemia in COVID-19 Infection: A Systematic Review
por: Brooks, Danielle, et al.
Publicado: (2022)

Stroke risk of COPD patients and death risk of COPD patients following a stroke: A systematic review and meta-analysis
por: Ding, Chaowei, et al.
Publicado: (2023)

Relationship between dietary patterns and COPD: a systematic review and meta-analysis
por: Parvizian, Michael K., et al.
Publicado: (2020)

Is COPD associated with alterations in hearing? A systematic review and meta-analysis
por: Bayat, Arash, et al.
Publicado: (2018)

Association between HMGB1 and COPD: A Systematic Review
por: Gangemi, Sebastiano, et al.
Publicado: (2015)

The relationship between hyperglycemia and the infection of COVID-19 in diabetic patients: A protocol for systematic review and meta-analysis
por: Liu, Yan, et al.
Publicado: (2020)

EPHX1 and GSTP1 polymorphisms are associated with COPD risk: a systematic review and meta-analysis
por: Yang, Qinjun, et al.
Publicado: (2023)

Association of the stress hyperglycemia ratio and clinical outcomes in patients with stroke: A systematic review and meta-analysis
por: Huang, Yong-Wei, et al.
Publicado: (2022)

The Therapeutic Index as Indicated by Efficacy/Safety Ratio May Be Primarily Assessed by Meta-Analysis of the Efficacy of ICS Combination Therapy for COPD [Letter]
por: Teramoto, Shinji
Publicado: (2022)

A COPD-like model of viral exacerbation: synergistic effects with smoke and poly I:C
por: Schlerman, F, et al.
Publicado: (2013)

Maintenance therapy in COPD: time to phase out ICS and switch to the new LAMA/LABA inhalers?
por: Tariq, Syed Mohammad, et al.
Publicado: (2017)

Sarcopenia in COPD: a systematic review and meta-analysis
por: Benz, Elizabeth, et al.
Publicado: (2019)

EVELUT®: A Real-World, Observational Study Assessing Dyspnoea and Symptom Burden in COPD Patients Switched from LABA/ICS to LAMA/LABA or LAMA/LABA/ICS
por: Buhl, Roland, et al.
Publicado: (2023)

Metabolic Effects Associated with ICS in Patients with COPD and Comorbid Type 2 Diabetes: A Historical Matched Cohort Study
por: Price, David B., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_pr2qjj7ddnck6rp2050ckel0hr